Most Enterobacter Aerogenes Strains in France Belong to a Prevalent Clone

Overview

Journal J Clin Microbiol

Specialty Microbiology

Date 1999 Jun 12

PMID 10364580

Citations 38

Authors

C Bosi

A Davin-Regli

C Bornet

M Mallea

J M Pages

C Bollet

Affiliations

Soon will be listed here.

Abstract

The aim of this study was to determine the distribution in France of the Enterobacter aerogenes prevalent clone isolated in the hospitals of the Marseille area (A. Davin-Regli, D. Monnet, P. Saux, C. Bosi, R. Charrel, A. Barthelemy, and C. Bollet, J. Clin. Microbiol. 34:1474-1480, 1996). A total of 123 E. aerogenes isolates were collected from 23 hospital laboratories and analyzed by random amplification of polymorphic DNA and enterobacterial repetitive intergenic consensus-PCR to determine their epidemiological relatedness. Molecular typing revealed that 21 of the 23 laboratories had isolated this prevalent clone harboring the plasmid encoding for extended-spectrum beta-lactamase of the TEM-24 type. Most isolates were susceptible only to imipenem and gentamicin. Their dissemination seems to be clonal and was probably the result of the general use of broad-spectrum cephalosporins and quinolones. Four isolates showed an alteration of their outer membrane proteins, causing decrease of susceptibility to third-generation cephalosporins and imipenem and leading to the critical situation of having no alternative therapeutic. The large dissemination of the E. aerogenes prevalent clone probably results from its good adaptation to the antibiotics administered in France and the hospital environment, particularly in intensive care units.

Citing Articles

Exploring the oral-gut linkage: Interrelationship between oral and systemic diseases.

Yamazaki K, Kamada N Mucosal Immunol. 2023; 17(1):147-153.

PMID: 38007003 PMC: 11222583. DOI: 10.1016/j.mucimm.2023.11.006.

Antimicrobial Resistance in ESKAPE Pathogens.

De Oliveira D, Forde B, Kidd T, Harris P, Schembri M, Beatson S Clin Microbiol Rev. 2020; 33(3).

PMID: 32404435 PMC: 7227449. DOI: 10.1128/CMR.00181-19.

spp.: Update on Taxonomy, Clinical Aspects, and Emerging Antimicrobial Resistance.

Davin-Regli A, Lavigne J, Pages J Clin Microbiol Rev. 2019; 32(4).

PMID: 31315895 PMC: 6750132. DOI: 10.1128/CMR.00002-19.

Detection of CTX-M-15 beta-lactamases in Enterobacteriaceae causing hospital- and community-acquired urinary tract infections as early as 2004, in Dar es Salaam, Tanzania.

Manyahi J, Moyo S, Tellevik M, Ndugulile F, Urassa W, Blomberg B BMC Infect Dis. 2017; 17(1):282.

PMID: 28415986 PMC: 5392921. DOI: 10.1186/s12879-017-2395-8.

Genome Sequencing of Four Multidrug-Resistant Isolates from Hospitalized Patients in Brazil.

Grazziotin A, Vidal N, Palmeiro J, Dalla-Costa L, Venancio T Front Microbiol. 2016; 7:1649.

PMID: 27833588 PMC: 5081556. DOI: 10.3389/fmicb.2016.01649.

References

Schaberg D, Culver D, Gaynes R . Major trends in the microbial etiology of nosocomial infection. Am J Med. 1991; 91(3B):72S-75S. DOI: 10.1016/0002-9343(91)90346-y. View

Mallea M, Chevalier J, Bornet C, Eyraud A, Davin-Regli A, Bollet C . Porin alteration and active efflux: two in vivo drug resistance strategies used by Enterobacter aerogenes. Microbiology (Reading). 1998; 144 ( Pt 11):3003-3009. DOI: 10.1099/00221287-144-11-3003. View

Versalovic J, Koeuth T, Lupski J . Distribution of repetitive DNA sequences in eubacteria and application to fingerprinting of bacterial genomes. Nucleic Acids Res. 1991; 19(24):6823-31. PMC: 329316. DOI: 10.1093/nar/19.24.6823. View

Jarvis W, Martone W . Predominant pathogens in hospital infections. J Antimicrob Chemother. 1992; 29 Suppl A:19-24. DOI: 10.1093/jac/29.suppl_a.19. View

Woods Jr C, Versalovic J, Koeuth T, Lupski J . Analysis of relationships among isolates of Citrobacter diversus by using DNA fingerprints generated by repetitive sequence-based primers in the polymerase chain reaction. J Clin Microbiol. 1992; 30(11):2921-9. PMC: 270553. DOI: 10.1128/jcm.30.11.2921-2929.1992. View

De Champs C, Henquell C, Guelon D, Sirot D, Gazuy N, Sirot J . Clinical and bacteriological study of nosocomial infections due to Enterobacter aerogenes resistant to imipenem. J Clin Microbiol. 1993; 31(1):123-7. PMC: 262633. DOI: 10.1128/jcm.31.1.123-127.1993. View

de Lamballerie X, Zandotti C, Vignoli C, Bollet C, De Micco P . A one-step microbial DNA extraction method using "Chelex 100" suitable for gene amplification. Res Microbiol. 1992; 143(8):785-90. DOI: 10.1016/0923-2508(92)90107-y. View

Nikaido H . Prevention of drug access to bacterial targets: permeability barriers and active efflux. Science. 1994; 264(5157):382-8. DOI: 10.1126/science.8153625. View

Tzouvelekis L, Tzelepi E, Kaufmann M, Mentis A . Consecutive mutations leading to the emergence in vivo of imipenem resistance in a clinical strain of Enterobacter aerogenes. J Med Microbiol. 1994; 40(6):403-7. DOI: 10.1099/00222615-40-6-403. View

10.

Chow J, Yu V, Shlaes D . Epidemiologic perspectives on Enterobacter for the infection control professional. Am J Infect Control. 1994; 22(4):195-201. DOI: 10.1016/0196-6553(94)90067-1. View

11.

Georghiou P, Hamill R, Wright C, Versalovic J, Koeuth T, WATSON D . Molecular epidemiology of infections due to Enterobacter aerogenes: identification of hospital outbreak-associated strains by molecular techniques. Clin Infect Dis. 1995; 20(1):84-94. DOI: 10.1093/clinids/20.1.84. View

12.

Mallea M, Simonet V, Lee E, Gervier R, Collatz E, Gutmann L . Biological and immunological comparisons of Enterobacter cloacae and Escherichia coli porins. FEMS Microbiol Lett. 1995; 129(2-3):273-9. DOI: 10.1111/j.1574-6968.1995.tb07592.x. View

13.

Grattard F, Pozzetto B, Tabard L, Petit M, Ros A, Gaudin O . Characterization of nosocomial strains of Enterobacter aerogenes by arbitrarily primed-PCR analysis and ribotyping. Infect Control Hosp Epidemiol. 1995; 16(4):224-30. DOI: 10.1086/647094. View

14.

Davin-Regli A, Saux P, Bollet C, Gouin F, De Micco P . Investigation of outbreaks of Enterobacter aerogenes colonisation and infection in intensive care units by random amplification of polymorphic DNA. J Med Microbiol. 1996; 44(2):89-98. DOI: 10.1099/00222615-44-2-89. View

15.

Davin-Regli A, Monnet D, Saux P, Bosi C, Charrel R, Barthelemy A . Molecular epidemiology of Enterobacter aerogenes acquisition: one-year prospective study in two intensive care units. J Clin Microbiol. 1996; 34(6):1474-80. PMC: 229045. DOI: 10.1128/jcm.34.6.1474-1480.1996. View

16.

Neuwirth C, Siebor E, Lopez J, Pechinot A, Kazmierczak A . Outbreak of TEM-24-producing Enterobacter aerogenes in an intensive care unit and dissemination of the extended-spectrum beta-lactamase to other members of the family enterobacteriaceae. J Clin Microbiol. 1996; 34(1):76-9. PMC: 228734. DOI: 10.1128/jcm.34.1.76-79.1996. View

17.

Livrelli V, De Champs C, Di Martino P, Darfeuille-Michaud A, Forestier C, Joly B . Adhesive properties and antibiotic resistance of Klebsiella, Enterobacter, and Serratia clinical isolates involved in nosocomial infections. J Clin Microbiol. 1996; 34(8):1963-9. PMC: 229163. DOI: 10.1128/jcm.34.8.1963-1969.1996. View

18.

Allerberger F, Koeuth T, Lass-Florl C, Dierich M, Putensen C, Scmutzhard E . Epidemiology of infections due to multiresistant Enterobacter aerogenes in a university hospital. Eur J Clin Microbiol Infect Dis. 1996; 15(6):517-21. DOI: 10.1007/BF01691323. View

19.

Arpin C, Coze C, Rogues A, Gachie J, Bebear C, Quentin C . Epidemiological study of an outbreak due to multidrug-resistant Enterobacter aerogenes in a medical intensive care unit. J Clin Microbiol. 1996; 34(9):2163-9. PMC: 229210. DOI: 10.1128/jcm.34.9.2163-2169.1996. View

20.

Charrel R, Pages J, De Micco P, Mallea M . Prevalence of outer membrane porin alteration in beta-lactam-antibiotic-resistant Enterobacter aerogenes. Antimicrob Agents Chemother. 1996; 40(12):2854-8. PMC: 163635. DOI: 10.1128/AAC.40.12.2854. View